Skip to main content

Table 1 Clinicopathological characteristics of SGC patient samples

From: Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy

  Number of cases (%)
Gender
Male 89 (56.0%)
Female 70 (44.0%)
Age (years)
≥47 81 (50.9%)
< 47 78 (49.1%)
Clinical Stage
I 16 (10.1%)
II 58 (36.5%)
III 39 (24.5%)
IV 46 (28.9%)
T classification
T1 17 (10.7%)
T2 72 (45.3%)
T3 37 (23.3%)
T4 33 (20.8%)
N classification
N0 118 (74.2%)
N1 21 (13.2%)
N2 20 (12.6%)
N3 0 (0.0%)
M classification
No 113 (71.1%)
Yes 46 (28.9%)
Pathologic Differentiation
Poor 101 (63.5%)
Moderate 4 (2.5%)
Well 54 (34.0%)
Histological Types
MEC 37 (23.3%)
ACC 23 (14.5%)
AcCC 18 (11.3%)
SDC 18 (11.3%)
Other histological types 63 (39.6%)
Vital status (at follow-up)
Alive 107 (67.3%)
Death (All Salivary Gland cancer-related) 52 (32.7%)
Adjuvant Therapy
Yes 50 (31.5%)
No 109 (68.6%)
\